Next Century Growth Investors LLC Edwards Lifesciences Corp Transaction History

Next Century Growth Investors LLC

$1.14 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $1.25 Million - $1.63 Million	-15,159 Reduced 40.94%	21,868 $1.81 Million
Q2 2022 Aug 12, 2022	BUY	$86.5 - $128.27 $10,553 - $15,648	122 Added 0.33%	37,027 $3.52 Million
Q1 2022 May 13, 2022	SELL	$101.96 - $128.34 $155,794 - $196,103	-1,528 Reduced 3.98%	36,905 $4.34 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $2,978 - $3,659	-28 Reduced 0.07%	38,433 $4.98 Million
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $1.29 Million - $1.54 Million	-12,558 Reduced 24.61%	38,461 $4.35 Million
Q2 2021 Aug 13, 2021	BUY	$83.84 - $104.76 $345,085 - $431,192	4,116 Added 8.78%	51,019 $5.28 Million
Q1 2021 May 14, 2021	BUY	$78.68 - $90.67 $864,535 - $996,281	10,988 Added 30.59%	46,903 $3.92 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $746,794 - $950,342	10,417 Added 40.85%	35,915 $3.28 Million
Q3 2020 Nov 13, 2020	SELL	$67.19 - $87.44 $210,775 - $274,299	-3,137 Reduced 10.96%	25,498 $2.04 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $1.1 Million - $1.47 Million	19,090 Added 200.0%	28,635 $1.98 Million
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $36,065 - $41,291	-503 Reduced 5.01%	9,545 $2.23 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $274,820 - $336,794	-4,465 Reduced 30.77%	10,048 $2.21 Million
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $41,805 - $48,307	-750 Reduced 4.91%	14,513 $2.68 Million
Q1 2019 May 14, 2019	BUY	$47.89 - $64.05 $434,601 - $581,253	9,075 Added 146.65%	15,263 $2.92 Million
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $176,914 - $217,055	-3,812 Reduced 38.12%	6,188 $947,000
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $234,166 - $297,345	-5,124 Reduced 33.88%	10,000 $1.74 Million
Q1 2018 May 14, 2018	SELL	$37.19 - $47.45 $353,937 - $451,581	-9,517 Reduced 38.62%	15,124 $2.11 Million
Q4 2017 Feb 13, 2018	SELL	$33.79 - $39.39 $122,150 - $142,394	-3,615 Reduced 12.79%	24,641 $2.78 Million
Q3 2017 Nov 14, 2017	SELL	$36.29 - $38.83 $86,878 - $92,959	-2,394 Reduced 7.81%	28,256 $3.09 Million
Q2 2017 Aug 14, 2017	BUY	N/A	30,650	30,650 $3.62 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

Vanguard Group Inc Valley Forge, PA

53.6M
Shares

$3.51 Billion
0.1% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.34 Billion
0.11% of portfolio
State Street Corp Boston, MA

26M
Shares

$1.7 Billion
0.11% of portfolio
Alliancebernstein L.P. New York, NY

20.3M
Shares

$1.33 Billion
0.68% of portfolio
Wellington Management Group LLP Boston, MA

16.9M
Shares

$1.11 Billion
0.29% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Next Century Growth Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Next Century Growth Investors LLC with notifications on news.

Account